SC 13D
ADMA BIOLOGICS, INC.
- Company
- ADMA BIOLOGICS, INC.
- Filed
- February 4, 2022
- Accession Number
- 0000902664-22-001112
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →